Colgate-Palmolive (NYSE:CL) Holdings Lowered by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund trimmed its stake in shares of Colgate-Palmolive (NYSE:CL) by 9.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 320,921 shares of the company’s stock after selling 34,549 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Colgate-Palmolive were worth $25,581,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CL. OFI Invest Asset Management acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $25,000. Avion Wealth grew its stake in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $34,000. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the last quarter. Finally, West Branch Capital LLC grew its stake in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Barclays lifted their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, April 12th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. UBS Group lifted their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Morgan Stanley lifted their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. Finally, The Goldman Sachs Group began coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $89.50.

Insider Buying and Selling at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the sale, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the sale, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jennifer Daniels sold 3,538 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the sale, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The disclosure for this sale can be found here. Insiders sold 232,371 shares of company stock worth $19,505,099 over the last ninety days. 0.37% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Up 1.4 %

NYSE CL traded up $1.20 during trading on Monday, reaching $88.33. The company’s stock had a trading volume of 3,951,985 shares, compared to its average volume of 4,563,458. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The stock has a market capitalization of $72.61 billion, a PE ratio of 31.77, a PEG ratio of 3.27 and a beta of 0.42. The business has a 50-day moving average price of $87.19 and a 200-day moving average price of $81.06. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The firm had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company’s revenue was up 6.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.77 earnings per share. On average, research analysts forecast that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a $0.50 dividend. The ex-dividend date is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a yield of 2.26%. Colgate-Palmolive’s payout ratio is 71.94%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.